MedTrace Logo

Research of Circulating Tumor Cells Released During Endometrial Cancer Surgery.

NCT04021459 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2023-10-03

No results posted yet for this study

Summary

The purpose of this study is to investigate the spread of Circulating Tumor Cells (CTC) during surgery in endometrial cancer. Although this cancer is often discovered at early stage, the risk of recurrence is estimated at 6 to 21%, according to grade. Early stage tumor is accessible for curative surgical treatment by laparoscopy but this kind of surgery may induce CTCs spread, and could be an explanation of this recurrence. Through this study, concordance between two blood punction sites, peripheral vein and ovarian vein, will be evaluated to detect these cells during surgery.

Conditions

Interventions

PROCEDURE

blood samples

3 samples: One before surgery on the arm vein (peripheral) Two during the surgery, on two different venipuncture site : * One on the arm vein (peripheral) * One on ovarian vein (close to the tumor) All samples will be tested by the CellSearch method.

Sponsors & Collaborators

  • University Hospital, Montpellier

    lead OTHER

Principal Investigators

  • Gauthier RATHAT, PHD · University of Montpellier

Study Design

Allocation
NA
Purpose
SCREENING
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-09-16
Primary Completion
2021-09-15
Completion
2021-09-16

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04021459 on ClinicalTrials.gov